Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
Launched by INDIANA UNIVERSITY · Apr 21, 2022
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The SPHERE Implementation Trial is a study designed to see how well a special health record helps cancer survivors manage their health after treatment. This trial focuses on patients who have been diagnosed with early-stage colon or rectal cancer and have recently completed their initial treatment. Researchers want to understand not only how effective this health record is in improving care but also how it can be successfully used in different healthcare settings.
To participate, you need to be at least 18 years old, have regular internet access, and be able to speak English. You should have been treated for colon or rectal cancer within the last year and not have had a recurrence of the cancer. If you join the study, you can expect to engage with the health record system and provide feedback about your experience. This trial is currently recruiting participants, and it offers an opportunity to contribute to improving cancer care for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients must be 18 years or older at the time of consent
- • 2. Patients must have regular (at least weekly) access to an internet connection, whether at home or elsewhere (family or friend).
- • 3. Diagnosis of colon or rectal cancer, Stages I, II, or III (AJCC, American Joint Committee on Cancer) and have undergone initial curative-intent therapy for their CRC diagnosis within the past 12 months.
- • 4. English-speaking
- Exclusion Criteria:
- • 1. Patient will be excluded if they have had recurrence of their colorectal cancer.
- • 2. Patient's with severe cognitive impairment
- • 3. Patient's with schizophrenia or other psychosis
- • 4. Patients currently in hospice care
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Indianapolis, Indiana, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials